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Abstract The aim of this study was to gain insight into the
mechanism through which transmembrane proteins are targeted
to liquid ordered (Lo) phase domains or rafts. This was inves-
tigated by analyzing the Triton X-100 resistance of designed
transmembrane peptides in model membranes of 1,2-dioleoyl-
sn-glycero-3-phosphocholine, sphingomyelin and cholesterol (1/
1/1, molar ratio), which contain both Lo phase domains and £uid
bilayers. By using peptides with one or two palmitate chains
covalently linked to their N-terminus or with variable hydro-
phobic lengths, the roles of protein palmitoylation and of mis-
match between the transmembrane segment of the protein and
the bilayer thickness, respectively, were investigated. The results
show that neither hydrophobic matching nor palmitoylation is
su⁄cient for partitioning of peptides into Lo phase domains. It
is concluded that the Lo phase itself, due to the tight packing of
the lipids, constitutes an unfavorable environment for accommo-
dation of protein transmembrane segments. , 2002 Federation
of European Biochemical Societies. Published by Elsevier Sci-
ence B.V. All rights reserved.
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1. Introduction
Much evidence has been found for the existence of sphin-
golipid and cholesterol rich lipid domains, called rafts, in the
eukaryotic cell membrane [1,2]. Lipid rafts are thought to be
in the liquid ordered (Lo) phase, which was ¢rst described
using model membranes [3^5]. The Lo phase arises from the
interaction of cholesterol with lipids with long saturated acyl
chains, like sphingolipids. Cholesterol stretches and orders
these chains, leading to an increase in membrane thickness
[6,7] and a tight packing of the acyl chains [8,9]. This tight
packing gives an explanation for the characteristic resistance
of Lo phase membranes to solubilization by non-ionic deter-
gents like Triton X-100 (TX-100) [10]. Detergent-resistant
membranes (DRMs) can indeed be isolated from both eukary-
otic cells and model membranes containing the Lo phase [11^
13].
Rafts have been proposed to play a role in several biolog-
ical processes, such as signal transduction [14], viral budding
[15] and lipid sorting [16]. Although many proteins have been
reported to be localized in rafts and/or to be enriched in
DRMs [17,18], little is known of the mechanisms with which
transmembrane proteins are targeted to rafts. One possible
mechanism is based on hydrophobic matching. It has been
shown that the bilayer thickness of a membrane with a raft-
like composition is larger than that of a £uid bilayer [11].
Since hydrophobic mismatch between a transmembrane K-he-
lix and the bilayer thickness of the membrane is energetically
unfavorable [19^21], it is possible that, in biological mem-
branes, proteins with transmembrane domains (TMDs) that
are too long to ¢t in a £uid bilayer preferentially partition
into the thicker rafts. Vice versa, proteins with shorter TMDs
that do ¢t in the £uid bilayer might be excluded from the rafts
due to mismatch. Such a mismatch-based mechanism has been
suggested to play a role in protein sorting in the Golgi. Plas-
ma membranes are expected to be thicker than Golgi mem-
branes, due to their higher content of cholesterol and long
chained sphingolipids. In accordance with this, it was found
that TMDs of plasma membrane proteins are on average ¢ve
residues longer than those of Golgi proteins [22]. Moreover, it
was shown that lengthening the TMD of a Golgi protein can
result in cell surface expression [23,24], while shortening the
TMD of a plasma membrane protein can lead to retention in
the Golgi [24]. These results support the notion that partition-
ing of proteins into membrane domains may be modulated by
the extent of hydrophobic matching.
Another possible mechanism for targeting both transmem-
brane and peripheral proteins into rafts may be protein acy-
lation. Many of the proteins that are enriched in DRMs from
cells are covalently modi¢ed with saturated fatty acyl chains,
which are expected to pack well in the Lo phase and to in-
crease the a⁄nity of the protein for Lo phase domains. These
modi¢cations are, for instance, GPI anchors, closely spaced
myristate and palmitate or dual palmitate chains [25^30]. Dis-
ruption of palmitoylation sites can result in the loss of asso-
ciation of a protein with DRMs [27,29]. It has therefore been
proposed that acylation and especially palmitoylation can act
as a targeting signal for partitioning into rafts [26,27,29].
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In the present study, we investigate the in£uence of hydro-
phobic length and palmitoylation on the partitioning of
TMDs into Lo phase domains. The properties of such do-
mains, as well as e¡ects of peptide/lipid hydrophobic mis-
match, have been well characterized in model membrane sys-
tems [3,11,31^34]. Therefore, we have chosen to use model
systems in which TMDs are mimicked by synthetic polypep-
tides. The peptides used consist of a sequence of alternating
leucine and alanine, £anked on both sides by two trypto-
phans. These peptides, called WALP peptides, form stable
transmembrane K-helices that incorporate well into model
membranes [35]. By varying the number of leucine and alanine
pairs, the in£uence of the hydrophobic length of these pep-
tides on their partitioning into Lo phase domains is studied.
The in£uence of palmitoylation is investigated by using pep-
tides to which one or two palmitate chains are covalently
linked to the N-terminus of the peptide.
2. Materials and methods
1,2-Dioleoyl-sn-glycero-3-phosphocholine (DOPC), cholesterol and
egg sphingomyelin were purchased from Avanti Polar Lipids
(Alabaster, AL, USA). Egg sphingomyelin consists of a mixture of
sphingomyelins with exclusively saturated acyl chains, mainly C16:0
acyl chains. The unpalmitoylated WALP peptides (Table 1) were syn-
thesized and analyzed by analytical high-performance liquid chroma-
tography (HPLC) and electrospray-mass spectrometry (ES-MS) as
described before [36].
2.1. Synthesis of palmitoylated peptides
The palmitoylated WALP peptides were prepared from a WALP23
derivative with a C-terminal amide group, which was synthesized and
analyzed by analytical HPLC and ES-MS as described for several
other WALP analogs [36]. After coupling of the ¢nal amino acid
and removal of the Fmoc functionality, the resin was split into three
portions. One portion was treated with acetic anhydride/N,N-diiso-
propylethylamine (DIPEA)/N-hydroxybenzotriazole (HOBt) in N-
methylpyrrolinone (NMP) for 30 min to yield WALP23 with an acetyl
group attached to the N-terminus. The second portion was reacted
with palmitic acid in the presence of benzotriazol-1-yl-oxy-tris-(dime-
thylamino)phosphonium hexa£uorophosphate (BOP)/HOBt and DI-
PEA in 1,2-dichloroethane (DCE)/NMP 1/1 v/v for 16 h to yield
WALP23 with one palmitate chain linked at the N-terminus via an
amide bond (1PW23). The third portion was treated with succinimid-
yl-Gluinv(OC16H33)-OC16H33/BOP/HOBt and DIPEA in DCE/NMP
1/1 v/v for 16 h to yield the WALP23 with two hexadecanyl chains
linked to the N-terminus (2PW23). In this construct, the two hexade-
canyl chains are esteri¢ed to the acid moieties of a glutamic acid,
which is connected to the peptide via succinimidyl as a £exible linker.
The succinimidyl-Gluinv(OC16H33)-OC16H33 was synthesized accord-
ing to [37]. When necessary (as judged by high performance thin layer
chromatography (TLC)), the peptides were further puri¢ed by prepa-
rative TLC on Merck Silicagel 60 F254 plates running with CHCl3/
MeOH/H2O (65/25/4, by volume) as liquid phase.
2.2. Preparation of multilamellar vesicles (MLVs)
DOPC and sphingomyelin (SM) were dissolved in CHCl3/MeOH
(1/1, by volume) as 10^20 mM stock solutions. The exact concentra-
tions of these stocks were determined by a phosphorus assay accord-
ing to Rouser [38]. Cholesterol was dissolved in CHCl3 (20 mM). The
concentration of WALP peptides, dissolved in tri£uoroethanol (TFE;
ca. 2 mM), was determined by the absorbance of tryptophan at 280
nm (O=22 400 M31 cm31). DOPC, SM and cholesterol were mixed in
solution in a 1/1/1, 1/2/1 or a 0/2/1 molar ratio. Where present, WALP
in TFE was added at 2 mol% with respect to the total amount of
phospholipids. This amount of peptide was chosen, because it can be
adequately detected in the presence of lipids without exceeding the
concentration at which the bilayer structure of a membrane would be
disturbed [39]. Next, organic solvents were evaporated using a rotary
evaporator. The resulting ¢lms were further dried by overnight stor-
age under high vacuum. Multilamellar vesicles were made by hydrat-
ing the mixed dry lipid or lipid/peptide ¢lms with bu¡er (20 mM Tris,
150 mM NaCl, pH 7.4) at 60‡C under repeated vortexing until the
¢lm was dispersed. The total lipid concentration was 4 mM. The
peptides have been shown to adopt a stable transmembrane confor-
mation when incorporated in MLVs using this method [35,36].
2.3. Treatment with TX-100
MLV dispersions were divided into two equal portions and cooled
on ice. A fourfold molar excess, with respect to the total amount of
lipid, of ice-cold 10% (w/w) TX-100 in bu¡er was added to one por-
tion, resulting in a ¢nal concentration of 1% TX-100. As a control,
the corresponding volume of bu¡er was added to the other portion.
The samples were incubated on ice for 30 min. Next, the DRMs in the
samples treated with TX-100 were separated from the dissolved mem-
brane fraction by ultracentrifugation at 200 000Ug for 1 h at 4‡C. The
membranes in the samples treated with bu¡er were spun down by
ultracentrifugation at 200 000Ug at 4‡C for 30 min or 1 h, with
similar results. All pellets were washed with MilliQ water and lyophi-
lized.
2.4. TLC analysis
Lyophilized pellets were dissolved in CHCl3/MeOH (3/1, by vol-
ume). Samples were analyzed by TLC with CHCl3/MeOH/H2O (65/
25/4, by volume) as liquid phase. Spots were visualized by I2 staining.
DOPC and SM spots were quanti¢ed by scraping the spots o¡ the
TLC plate, followed by a phosphorus determination according to
Rouser [38]. s 80% of the original amount of DOPC and SM was
recovered from the pellet fraction after TLC when samples had been
treated with bu¡er. Peptide spots were quanti¢ed by densitometry
after scanning the TLC plate. The detergent resistance of the lipids
and peptides is de¢ned as the percentage of the amount of material
that was pelleted after treatment with TX-100 as compared to the
amount of material that was pelleted after treatment with bu¡er.
The experimental error in the values of the detergent resistance did
not exceed 20% of those values.
3. Results
3.1. TX-100 resistance of lipids
First, the resistance to TX-100 was checked of di¡erent
mixtures of the non-raft lipid DOPC, the raft lipid SM and
cholesterol in the absence of peptide. Fig. 1A shows that, after
treatment of a 2/1 mixture of SM and cholesterol with either
TX-100 (lane 2) or bu¡er (lane 1), similar amounts of SM are
pelleted. This high detergent resistance of SM implies that this
mixture consists mainly of DRM. When DOPC is incorpo-
rated together with SM and cholesterol in a 1/1/1 molar ratio,
again similar amounts of SM are pelleted after treatment of
this mixture with TX-100 (lane 4) or bu¡er (lane 3). In con-
trast, most of the DOPC in the 1/1/1 mixture is dissolved by
TX-100 (lane 4) as compared to treatment with bu¡er (lane 3).
Quanti¢cation (Fig. 1B) shows that the detergent resistance of
SM is indeed high and comparable in both mixtures, whereas
that of DOPC in the 1/1/1 mixture amounts to only 30%, in
agreement with results from earlier studies [11,12]. Mixtures
lacking either SM or cholesterol were completely dissolved by
TX-100 (data not shown).
Table 1
Amino acid sequences of the WALP peptides used
Peptide Sequence
WALP23 Ac-GWWLALALALALALALALALWWA-Etna
WALP27 Ac-GWWLALALALALALALALALALALWWA-Etn
WALP31 Ac-GWWLALALALALALALALALALALALALWWA-
Etn
aA WALP23 with an amide group linked to the C-terminus instead
of an ethanolamine group was used where mentioned.
FEBS 26244 8-7-02 Cyaan Magenta Geel Zwart
B.Y. van Duyl et al./FEBS Letters 523 (2002) 79^8480
3.2. Hydrophobic matching of transmembrane peptides
In order to investigate the in£uence of hydrophobic match-
ing on the partitioning of TMDs of proteins into lipid rafts,
WALPs with three di¡erent hydrophobic lengths were incor-
porated into MLVs containing DOPC, SM and cholesterol in
a 1/1/1 ratio. The detergent resistances of DOPC and SM
appear to be rather similar in the presence of peptides (Fig.
2A) and in the absence of peptides (Fig. 1A, lanes 3,4). The
peptides themselves can be easily visualized on TLC (Fig. 2A),
well separated from any lipid spots. The shortest peptide,
WALP23, has a hydrophobic length that is expected to match
well with that of a DOPC bilayer [35]. This peptide (Fig. 2A,
lanes 1,2) was mostly dissolved by TX-100 from MLVs con-
taining DOPC, SM and cholesterol in a 1/1/1 ratio (16% re-
mained undissolved, Fig. 2B). This suggests that WALP23
had partitioned into the £uid, DOPC containing bilayer, as
expected on the basis of mismatch dependent sorting. How-
ever, the longer peptides WALP27 and WALP31 (lanes 3,4
and 5,6, respectively) were also mostly dissolved by TX-100
(14% and 3% remained undissolved, respectively, Fig. 2B).
Thus, increasing the hydrophobic length of the WALP pep-
tides and thereby the mismatch with the £uid bilayer does not
appear to result in increased DRM association.
The detergent resistance of the di¡erent length peptides was
also determined in a pure raft-like mixture of SM and choles-
terol in a 2/1 molar ratio. For each of the WALP peptides it
was found that in this mixture the detergent resistance was
much higher than when DOPC was also present (Fig. 2B). A
Fig. 1. Detergent resistance of SM and DOPC in di¡erent mixtures
of DOPC, SM and cholesterol. A: TLC analysis of the pellets after
treatment of MLVs with either bu¡er (3) or 1% TX-100 (+). The
MLVs initially contained DOPC, SM and cholesterol (CHOL) at
the indicated molar lipid ratios (0/2/1 and 1/1/1). B: Quanti¢cation
of the detergent resistance of SM (¢lled bars) and DOPC (open
bars) in these MLVs. The detergent resistance is de¢ned as the per-
centage of the amount of lipid that was pelleted after treatment
with TX-100 as compared to the amount of lipid that was pelleted
after treatment with bu¡er.
Fig. 2. DRM association of WALP peptides with di¡erent hydro-
phobic lengths. A: TLC analysis of the pellets after treatment of
MLVs with either bu¡er (3) or 1% TX-100 (+). The MLVs initially
contained DOPC, SM and cholesterol in 1/1/1 ratio and 2%
WALP23 (W23), WALP27 (W27) or WALP31 (W31). The C-termi-
nus of each of these peptides is capped with an ethanolamine group.
B: Quanti¢cation of the detergent resistance of these peptides in
MLVs containing DOPC, SM and CHOL in a 1/1/1 (¢lled bars) or
a 0/2/1 (open bars) ratio.
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mixture of SM and cholesterol in a 2/1 molar ratio has been
shown to be structurally comparable to DRMs, obtained from
a mixture of DOPC, SM and cholesterol in a 1/1/1 ratio by
treatment with 1% TX-100 [11]. Therefore, these results sug-
gest that the high degree of solubilization of the peptides from
MLVs with DOPC is due to the presence of a £uid, DOPC
containing bilayer and hence that all three peptides preferen-
tially partition into the £uid bilayer.
3.3. Palmitoylation of transmembrane peptides
In order to test whether palmitoylation can facilitate the
partitioning of TMDs of proteins into lipid rafts, unpalmitoy-
lated WALP23 or WALP23 with one or two palmitate chains,
covalently linked to the N-terminus, were incorporated into
MLVs with a 1/1/1 ratio of DOPC, SM and cholesterol. Pal-
mitoylation causes an increase in the Rf values of the pep-
tides, re£ecting the increase in hydrophobicity (Fig. 3A). The
minor peptide spots with smaller Rf values re£ect the small
amounts of non-palmitoylated peptides generated by the ex-
perimental procedure. Fig. 3A (lanes 3,4 and 5,6) shows that
the peptides with one or two palmitate chains behave similarly
to the unpalmitoylated peptide (lanes 1,2) in that they are
mostly dissolved by TX-100. Quanti¢cation reveals that in-
creasing the degree of palmitoylation causes a slight, but
not signi¢cant, decrease in detergent resistance (Fig. 3B).
This suggests that palmitoylation of WALP23 is not su⁄cient
to allow the association of this peptide with DRMs.
The detergent resistance of the single and double palmitoy-
lated WALP23 peptides was much higher in a pure raft-like
mixture of SM and cholesterol in a 2/1 molar ratio (Fig. 3B),
as was also observed for the di¡erent length analogs, and did
not show a clear dependency on degree of palmitoylation. The
results indicate that it is the presence of a £uid, DOPC con-
taining bilayer that leads to the solubilization of both the
unpalmitoylated and the palmitoylated WALP23 from
MLVs containing DOPC, SM and cholesterol.
4. Discussion
4.1. In£uence of mismatch on DRM association
Before discussing the e¡ect of mismatch, we must estimate
the extent of the mismatch between the hydrophobic length of
the peptides and the bilayer thicknesses of the Lo phase do-
mains and the £uid bilayer. An X-ray study has shown that
the bilayer thickness of DRMs, isolated from a 1/1/1 mixture
of DOPC, SM and cholesterol by treatment with 1% TX-100,
amounts to approximately 47 AV between the lipid headgroups.
The thickness of the £uid bilayer in this mixture was shown to
be 38 AV [11]. From these headgroup^headgroup distances, it
can be estimated [40] that the hydrophobic thicknesses of the
DRMs and the £uid bilayer amount to approximately 36 AV
and 27 AV , respectively.
The optimal bilayer thicknesses for matching the di¡erent
hydrophobic lengths of the peptides can be estimated from
their incorporation e⁄ciencies in PC bilayers with varying
thickness [35]. Based on these studies, the hydrophobic length
of WALP23 (approximately 25.5 AV ) would ¢t well in the £uid
bilayer. The longer WALP27 (approximately 31.5 AV ) could be
accommodated by both types of bilayer, while the longest
peptide, WALP31 (approximately 37.5 AV ), is expected to ¢t
better into the DRMs than the £uid bilayer. Therefore, in a
1/1/1 mixture of DOPC, SM and cholesterol, the DRM asso-
ciation of these peptides after treatment with TX-100 could be
expected to increase with their length, if hydrophobic match-
ing is indeed an important parameter. However, we found
that all three peptides were mostly dissolved by TX-100
from MLVs containing DOPC, SM and cholesterol in a
1/1/1 ratio. In fact, WALP31 was even more dissolved than
WALP23 and WALP27. Thus, increasing the hydrophobic
length of the WALP peptides does not result in an increase
in their DRM association in MLVs containing a £uid bilayer
and Lo phase domains.
The most logical explanation for these observations is re-
lated to the tight packing of the lipid acyl chains in the Lo
phase. This may constitute an energetically unfavorable envi-
Fig. 3. DRM association of unpalmitoylated WALP23 and
WALP23 with one or two palmitate chains. A: TLC analysis of the
pellets after treatment of MLVs with either bu¡er (3) or 1% TX-
100 (+). The MLVs initially contained DOPC, SM and cholesterol
in 1/1/1 ratio and 2% unpalmitoylated WALP23 (W23) or WALP23
with one (1PW23) or two (2PW23) palmitate chains covalently
linked to the N-terminus. The C-terminus of each of these peptides
is capped with an amide group. B: Quanti¢cation of the detergent
resistance of these peptides in MLVs containing DOPC, SM and
CHOL in a 1/1/1 (¢lled bars) or a 0/2/1 (open bars) ratio.
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ronment for the WALP peptides, impairing the partitioning of
the peptides into the Lo phase domains. Consequently, the
peptides will partition in the £uid, DOPC containing bilayer
and thereby become detergent solubilized together with the
DOPC. It is possible that the peptides somewhat facilitate
the solubilization of DOPC by TX-100 by inducing local dis-
turbances in the bilayer. The extent of these disturbances
could increase with the mismatch between the peptides and
the £uid bilayer, thereby increasing the accessibility of the
longer peptides to TX-100. This would explain the observed
increased solubilization of WALP31 as compared to the other
peptides.
In the absence of DOPC, the peptides can to some extent be
forced to incorporate into the Lo phase, since the DRM asso-
ciation of the peptides was much higher in MLVs containing
only SM and cholesterol in a 2/1 molar ratio. This indicates
that the low detergent resistance of the WALPs in the 1/1/1
mixture of DOPC, SM and cholesterol is due to the presence
of the £uid, DOPC containing bilayer. However, the peptides
were not fully detergent-resistant in the 2/1 mixture of SM
and cholesterol, probably because the tight packing of the
Lo phase in this mixture still constitutes an unfavorable envi-
ronment for the peptides and may impair the homogeneous
mixing of the peptides with the lipids. This might result in
clustering of peptides or the sequestering of peptides to sites
in the bilayer where they disturb lipid packing, both increas-
ing their accessibility to TX-100. The extent of clustering or
perturbation of packing in peptide rich sites could well be
dependent on the type of peptide. This would then explain
the dependence of the detergent resistance of the peptides
on the type of peptide in a 2/1 mixture of SM and cholesterol.
4.2. In£uence of palmitoylation on DRM association
Palmitate chains are saturated and are expected to pack
well into Lo phase domains. Therefore, covalently linking
palmitate chains to the N-terminus of a WALP peptide can
be expected to improve the a⁄nity of the peptides for the Lo
phase domains and thereby their DRM association. However,
the detergent resistance of the palmitoylated peptides was very
similar to that of the unpalmitoylated peptides, both in the
presence and the absence of DOPC in the MLVs. It can be
concluded that the single or double palmitoylation of the
WALP peptide does not result in a signi¢cant increase in its
DRM association in MLVs containing a £uid, DOPC con-
taining bilayer and Lo phase domains. The most likely expla-
nation for this is that the palmitate chains are unable to suf-
¢ciently improve the a⁄nity of the peptides for the Lo phase
to overcome the preference of the peptides for partitioning
into the £uid bilayer. Alternatively, it is possible that the pep-
tides are located at the interface of the Lo phase domains and
the £uid bilayer, possibly with the palmitate chains inserted in
the Lo phase, while remaining accessible to TX-100.
4.3. Relevance to biological membranes
The ¢nding that increasing the hydrophobic length of a
transmembrane peptide does not increase its association
with the DRMs strongly suggests that hydrophobic matching
is insu⁄cient to cause integration of membrane proteins with
long TMDs into rafts in biological membranes. Palmitoyla-
tion of transmembrane peptides also did not lead to enhanced
DRM association, which suggests that palmitoylation of
transmembrane proteins cannot be a general determinant for
association of such proteins with DRMs obtained from bio-
logical membranes. This is consistent with the ¢nding that not
all transmembrane proteins that are associated with DRMs
are palmitoylated. However, palmitoylation appears to play
an essential role in the targeting of some proteins into rafts
[26,29]. We propose that mechanisms such as hydrophobic
mismatch and palmitoylation can only play a role in targeting
transmembrane proteins into rafts if certain requirements are
met for the insertion of TMDs into the tightly packed lipid
environment of rafts. These requirements could be related to
both the amino acid composition of the TMD and the exact
lipid composition of the raft. Indeed, the amino acid compo-
sition of the TMD has been shown to play a role in the DRM
association of some proteins [41^43], although a consensus
sequence has yet to be found. Furthermore, the composition
of rafts in biological membranes will be much more complex
than in the model systems studied here and, consequently,
packing properties may be di¡erent. Moreover, lipids are
asymmetrically distributed over both lea£ets of the plasma
membrane. The signi¢cance of this asymmetry is shown by
the observation that raft association of in£uenza virus hem-
agglutinin is more dependent on the amino acid composition
of the TMD at the exoplasmic side than on that at the cyto-
plasmic side [41]. Although sphingolipids are primarily lo-
cated in the exoplasmic lea£et [44], rafts probably also exist
in the cytoplasmic lea£et. It is possible that such cytoplasmic
rafts have packing properties that are less stringent than those
of exoplasmic rafts, as is suggested by the sequence depen-
dence of hemagglutinin raft association [41]. Considering that
the palmitate chains of palmitoylated proteins usually reside
in the cytoplasmic lea£et, palmitoylation might then only in-
crease the a⁄nity of proteins for rafts with moderately tight
packing properties.
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